I rate Cognition Therapeutics a "Strong Buy" due to FDA alignment on two pivotal phase 3 trials zervimesine in mild-to-moderate Alzheimer's patients with low p-tau217; Successful results means NDA ...

O'Connell projected, "We expect to read out ALTITUDE-AD late this year, inclusive of key clinical efficacy and safety measures." He indicated that results from this study would inform development ...

Sociable is the latest commentary on important social media developments and trends from industry expert Andrew Hutchinson of Social Media Today. Meta has rolled out an improved ad serving process for ...